bioAffinity Technologies, Inc. (BIAF)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.00M
Last updated: Nov 17, 2026 at 11:04 AM ET
bioAffinity Technologies, Inc. (BIAF) Earnings: Report Dates and Results
bioAffinity Technologies (BIAF) is expected to report earnings on Mar 11, 2027. In the quarter ended Sep 30, 2026, bioAffinity Technologies reported EPS of -$3.94. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
BIAF has an expected report date of Mar 11, 2027.
Earnings History
Of the 12 quarters below that had an estimate, BIAF beat 1, missed 7 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $1.07M, down 26.2% from $1.45M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$3.94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 6, 2026 | $1.07M |
| Jun 30, 2026 | -$0.64 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 7, 2026 | $1.51M |
| Mar 31, 2026 | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 8, 2026 | $1.35M |
| Dec 31, 2025 | -$10.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 13, 2026 | $1.59M |
| Sep 30, 2025 | -$4.74 | -$2.70 | -$2.70 - -$2.70 | -75.56% | Miss | N/A | 1 | 0 up, 1 down | Nov 14, 2025 | $1.45M |
| Jun 30, 2025 | -$0.17 | -$0.10 | -$0.10 - -$0.10 | -70.00% | Miss | N/A | 1 | 1 up, 0 down | Aug 14, 2025 | $1.27M |
| Mar 31, 2025 | -$0.16 | -$0.17 | N/A | +5.88% | Beat | N/A | 1 | 1 up, 0 down | May 15, 2025 | $1.85M |
| Dec 31, 2024 | -$0.19 | -$0.14 | -$0.14 - -$0.14 | -35.71% | Miss | N/A | 1 | 0 up, 0 down | Mar 31, 2025 | $2.21M |
| Sep 30, 2024 | -$0.16 | -$0.15 | -$0.15 - -$0.15 | -6.67% | Miss | N/A | 1 | 0 up, 0 down | Nov 14, 2024 | $2.35M |
| Jun 30, 2024 | -$0.19 | -$0.17 | -$0.17 - -$0.17 | -11.76% | Miss | N/A | 1 | 0 up, 0 down | Aug 14, 2024 | $2.40M |
| Mar 31, 2024 | -$0.26 | -$0.20 | N/A | -28.35% | Miss | N/A | N/A | N/A | Apr 1, 2024 | $2.41M |
| Dec 31, 2023 | Not reported | -$0.20 | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 5, 2024 | $2.21M |
| Sep 30, 2023 | -$0.26 | -$0.15 | N/A | -73.33% | Miss | N/A | N/A | N/A | Nov 14, 2023 | $298484 |
| Jun 30, 2023 | -$0.20 | -$0.20 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 14, 2023 | $19738 |
| Mar 31, 2023 | -$0.18 | -$0.18 | N/A | 0.00% | In line | N/A | N/A | N/A | May 15, 2023 | $921 |
| Dec 31, 2022 | -$0.19 | -$0.19 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 31, 2023 | $2346 |
| Sep 30, 2022 | -$1.17 | -$1.17 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 14, 2022 | $1150 |
| Jun 30, 2022 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 2, 2022 | $1306 |
| Mar 31, 2022 | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 16, 2022 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$15.53, after -$0.80 the year before. It was -$1.87 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$15.53 | N/A |
| Dec 31, 2024 | -$0.80 | N/A |
| Dec 31, 2023 | -$0.64 | N/A |
| Dec 31, 2022 | -$1.87 | N/A |
Frequently Asked Questions About BIAF
When is bioAffinity Technologies's next earnings date?
bioAffinity Technologies's next earnings report is expected for Mar 11, 2027.
How often does BIAF beat earnings estimates?
bioAffinity Technologies beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -36.94%.
BIAF pages: Overview, Earnings, Financials, Competitors